Sean Mackay

This profile gathers the share dealings of Sean Mackay across 2 companies, led by Standard Biotools Inc. and IsoPlexis Corp. We count 12 filings; the first trade dates from 19 August 2022 and the latest from 20 August 2026.

Both buying and selling appear: 1 purchase worth €30k, against 2 sales worth €23k. Taken together, the purchases exceed the sales by €7,242. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants and 1 option exercise.

Most recently, on 24 August 2026, the filings show a share grant worth €15k in Standard Biotools Inc. The most recent open-market purchase was published on 29 August 2022, 1,511 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.